Endocrinology News and Research

Latest Endocrinology News and Research

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Adeona Pharmaceuticals, Inc., announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline.

12 Oct 2010

Minnesota Foundation announces collaborative effort to improve health of underserved populations

In a report released this week, the Blue Cross and Blue Shield of Minnesota Foundation highlights the accomplishments of a collaborative effort to improve the health of underserved populations through the training and use of community health workers, titled Community health workers in Minnesota: Bridging barriers, expanding access, improving health.

12 Oct 2010

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

Boehringer Ingelheim announced today that the European Commission confirmed the positive opinion of the European Medicines Agency (EMA) approving TWYNSTA. TWYNSTA is indicated for the treatment of hypertension in adults whose blood pressure is not adequately controlled on amlodipine or as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets containing the same component doses.

12 Oct 2010

Global study finds new set of genes associated with body fat distribution and obesity

Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.

12 Oct 2010

WHO Western Pacific meeting to address maternal health, rise in dengue

Maternal health and dengue fever are among the issues that will be discussed at the 61st session of the WHO Regional Committee for the Western Pacific, Bernama reports.

12 Oct 2010

Persistent exposure to light at night leads to weight gain

Persistent exposure to light at night may lead to weight gain, even without changing physical activity or eating more food, according to new research in mice.

12 Oct 2010

Study finds rapid increase in diabetes hospitalizations among young women

A study published in Journal of Women's Health shows a rapid increase in the number of hospitalizations due to diabetes for young adults - particularly young women.

12 Oct 2010

Halozyme Therapeutics to advance core proprietary programs through key clinical inflection points

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced a focusing of its resources on advancing its core proprietary programs through key clinical inflection points in 2011 and 2012, and supporting strategic alliances with Roche and Baxter such as validation of Halozyme's commercial scale manufacturing process to produce kilogram quantities of enzyme.

12 Oct 2010

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

12 Oct 2010

Insulin resistance increases risk of stroke in non-diabetic patients

Insulin resistance, a condition in which insulin produced by the body becomes less effective in reducing blood glucose levels, appears to be associated with an increased risk of stroke in individuals without diabetes, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.

12 Oct 2010

Research reveals new details about health benefits of fish-oil

Some of America's most popular fish salmon and albacore tuna, for example are rich in healthful natural compounds known as omega-3 fatty acids. Ongoing studies by U.S. Department of Agriculture (USDA) chemist Darshan S. Kelley and co-investigators are helping uncover new details about how these fish-oil components help protect us from chronic diseases.

12 Oct 2010

Abiraterone acetate improves survival in metastatic castration-resistant prostate cancer

Patients with metastatic castration-resistant prostate cancer who have progressed after chemotherapy live significantly longer if treated with the drug abiraterone acetate compared to placebo, the results of a large Phase-III clinical trial confirm.

11 Oct 2010

Embryonic stem cells used in first trial for spinal cord injury

The first ever patient to receive treatment in a U.S. government approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells. He is presently being treated at the Shepherd Center in Atlanta. He was partially paralyzed following a spinal cord injury. The center specializes in treating these types of injuries.

11 Oct 2010

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

In another article being released early online, Cheryl L. Rock, Ph.D., R.D., from Moores UCSD Cancer Center, La Jolla, Calif., and colleagues, conducted a randomized controlled trial of weight loss and weight maintenance in 442 overweight or obese women (BMI, 25 - 40), ages 18 to 69, over a two year period with follow-up between November 2007 and April 2010.

11 Oct 2010

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the first results from the BALI-1 study of Erbitux® (cetuximab) in the treatment of metastatic triple-negative breast cancer (TNBC), an aggressive cancer in which early relapse and metastasis are common. The data, presented during the 35th Congress of the European Society for Medical Oncology (ESMO), demonstrate that Erbitux has the potential to improve outcomes for women with this relentlessly devastating cancer.

11 Oct 2010

Generex to acquire majority interest in Global Medical Direct

Generex Biotechnology Corporation today announced that it has entered into a definitive agreement to acquire a majority interest (51%) in Global Medical Direct, LLC of Lenexa, Kansas, a nationwide Durable Medical Equipment and Pharmaceutical provider specializing in direct-to-consumer diabetes supplies and medications.

11 Oct 2010

NCQA recertifies Lilly's online Health Education Answers program

Lilly's Health Education Answers program, an interactive online health and wellness tool, has received Health Information Product Recertification from the National Committee for Quality Assurance (NCQA).

11 Oct 2010

Florida Governor issues Proclamation recognizing outstanding work of Healthcare Quality Professionals

Florida Governor Charlie Crist issued a Proclamation recognizing the outstanding work Healthcare Quality Professionals do for the people of Florida. This proclamation mirrors the sentiments of National Healthcare Quality Week, October 17-23rd, which celebrates the work of Healthcare Quality Professionals in improving patient outcomes and healthcare delivery systems.

11 Oct 2010

OXiGENE announces ZYBRESTAT Phase 2/3 study results at ESMO Congress

OXiGENE, a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that an ongoing analysis of positive results reported earlier from a randomized, controlled, Phase 2/3 study of ZYBRESTAT (fosbretabulin, CA4P) were presented today at the 35th European Society of Medical Oncology (ESMO) Congress in Milan, Italy by Julie Ann Sosa, M.D., F.A.C.S., of Yale University.

11 Oct 2010

NIH awards La Jolla Institute $12.6M to develop San Diego's first Center for RNAi screening

The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening -- a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.

11 Oct 2010

Endocrinology News and Research

Latest Endocrinology News and Research

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Minnesota Foundation announces collaborative effort to improve health of underserved populations

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

Global study finds new set of genes associated with body fat distribution and obesity

WHO Western Pacific meeting to address maternal health, rise in dengue

Persistent exposure to light at night leads to weight gain

Study finds rapid increase in diabetes hospitalizations among young women

Halozyme Therapeutics to advance core proprietary programs through key clinical inflection points

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Insulin resistance increases risk of stroke in non-diabetic patients

Research reveals new details about health benefits of fish-oil

Abiraterone acetate improves survival in metastatic castration-resistant prostate cancer

Embryonic stem cells used in first trial for spinal cord injury

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Generex to acquire majority interest in Global Medical Direct

NCQA recertifies Lilly's online Health Education Answers program

Florida Governor issues Proclamation recognizing outstanding work of Healthcare Quality Professionals

OXiGENE announces ZYBRESTAT Phase 2/3 study results at ESMO Congress

NIH awards La Jolla Institute $12.6M to develop San Diego's first Center for RNAi screening

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Endocrinology News and Research

Latest Endocrinology News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in